Bardan I, Uhlig T, Sexton J, Kvien TK, Bakland G, Mielnik P, Hu Y, Molberg Ø, Aga AB, Kristianslund EK(2026) Health-Related Quality of Life in Disease-Modifying Antirheumatic Drug-Treated Adults With Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population J Rheumatol, 53(1), 77-84 DOI 10.3899/jrheum.2025-0384, PubMed 40890003
Hetlevik SO, Lilleby V, Pesonen M, Nordal E, Rygg M, Austad C, Jonsson MK, Bilstad M, Høiberg HK, Sande NK, Flatø B, Lillegraven S, Haavardsholm EA, Ramanan AV, Molberg Ø, Bøyesen P, Aga AB(2026) Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial Trials, 27(1) DOI 10.1186/s13063-026-09539-0, PubMed 41703606
Mørk R, Bøyesen P, Kindem IA, Lilleby J, Gunnarsson R, Molberg Ø, Lilleby V(2026) Avacopan as an add-on therapy in a paediatric patient with new-onset granulomatosis with polyangiitis and acute kidney injury: a case report Rheumatology (Oxford), 65(1) DOI 10.1093/rheumatology/keaf523, PubMed 41075162
